# Florent Gros

> Florent Gros is a Series B investor at Priothera (Basel) backing Health Care and Biotechnology. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Priothera](https://shizune.co/investors/profile/priothera)
- Location: Basel, Switzerland
- Total investments: 2
- Last investment: Oct 2013
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/pub/florent-gros/6/aa8/59a

Florent Gros is a Series B investor at Priothera in Basel focused on Health Care and Biotechnology. Florent Gros is the Chairman & Founder at Amyl Therapeutics. He attended University of Mulhouse.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 100% |
| Biotechnology | 2 | 100% |
| Medical | 1 | 50% |
| Therapeutics | 1 | 50% |
| Health Diagnostics | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 1 | 50% |
| Series C | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| France | 1 | 50% |
| Ireland | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Opsona | Drug development firm focused on immunology. They are headquartered in Dublin, Ireland. Opsona Therapeutics is one of Europe's most innovative and dynamic drug development companies. We are at the forefront of drug development in immunology research, with particular focus on the innate immunity pathways. Since its founding in 2004,Opsona has validated and developed a series of exciting new drug candidates and strategies which modulate the human innate immune system. We are located in Dublin, Ireland. | $3.3M | Series C | Oct 02, 2013 |  |
| Myopowers Medical Technologies | Myopowers Medical Technologies is a French medical device company that develops innovative technologies to provide muscle assistance to patients with high unmet medical needs. The technology can be applied to a number of indications in the GI, cardiology or urology area.The company focus is the development of ARTUS, a new and unique implantabledevice for the treatment of stress urinary incontinence. Stress urinary incontinence is a condition that affects millions of people around the world. Unfortunately, currently available products are old with significant limitations such as tissue erosion, infection or mechanical failure leading frequent re-operation.ARTUS is made of smooth and flat silicon cuff placed around the urethra. It is individually actionable and adjustable with a remote control allowing patients easy voiding and the surgeon monitoring and adjusting the cuff. This device is the first artificial urinary system specifically designed to include the treatment of female patients who account for a vast majority of the urinary incontinence market. | $16M | Series B | Jul 05, 2011 |  |

2 of 2 investments shown.

## Co-investors
- [Amgen Ventures](https://shizune.co/investors/profile/amgen-ventures) — VC Fund, 1 deal together
- [Baxter International](https://shizune.co/investors/profile/baxter-international) — VC Fund, 1 deal together
- [BB Biotech Ventures](https://shizune.co/investors/profile/bb-biotech-ventures) — VC Fund, 1 deal together
- [BlueOcean Ventures](https://shizune.co/investors/profile/blueocean-ventures) — VC Fund, 1 deal together
- [EMBL Ventures](https://shizune.co/investors/profile/embl-ventures) — VC Fund, 1 deal together
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund, 1 deal together

## About Priothera

VC Fund · Dublin, Ireland

Priothera is a clinical-stage company developing orally applied sphingosine 1 phosphate (S1P) receptor modulators for haematological malignancies. We are dedicated to improving the lives of patients suffering from hematological malignancies by delivering an innovative immune modulator to enhance the curative potential of allogeneic HematopoieticStem Cell Transplantation (HSCT) in these patients.

5 contacts available at Priothera.

| Name | Title | Profile |
| --- | --- | --- |
| Brice Suire | Chief Financial Officer | https://shizune.co/investors/profile/brice-suire-2 |
| Dhaval Patel | Founder & Director | https://shizune.co/investors/profile/dhaval-patel-d8c1 |
| Elisabeth Kueenburg | Chief Medical Officer | https://shizune.co/investors/profile/elisabeth-kueenburg |
| Florent Gros | CEO & Founder | https://shizune.co/investors/profile/florent-gros-4c33 |
| Florent Gros | CEO & Founder | https://shizune.co/investors/profile/florent-gros |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Florent Gros invest in?

Florent Gros invests primarily in Health Care, Biotechnology and Medical startups, most often at Series B and Series C stage. Most of the 2 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Florent Gros last invest?

The most recent investment recorded for Florent Gros closed in Oct 2013. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co